Nobiletin inhibits angiogenesis by regulating Src/FAK/STAT3-mediated signaling through PXN In ER+ breast cancer cells

21Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Tumor angiogenesis is one of the major hallmarks of tumor progression. Nobiletin is a natural flavonoid isolated from citrus peel that has anti-angiogenic activity. Steroid receptor coactivator (Src) is an intracellular tyrosine kinase so that focal adhesion kinase (FAK) binds to Src to play a role in tumor angiogenesis. Signal transducer and activator of transcription 3 (STAT3) is a marker for tumor angiogenesis which interacts with Src. Paxillin (PXN) acts as a downstream target for both FAK and STAT3. The main goal of this study was to assess inhibition of tumor angiogenesis by nobiletin in estrogen receptor positive (ER+) breast cancer cells via Src, FAK, and STAT3-mediated signaling through PXN. Treatment with nobiletin in MCF-7 and T47D breast cancer cells inhibited angiogenesis markers, based on western blotting and RT-PCR. Validation of in vitro angiogenesis in the human umbilical vein endothelial cells (HUVEC) endothelial cell line proved the anti-angiogenic activity of nobiletin. Electrophoretic mobility shift assay and the ChIP assay showed that nobiletin inhibits STAT3/DNA binding activity and STAT3 binding to a novel binding site of the PXN gene promoter. We also investigated the migration and invasive ability of nobiletin in ER+ cells. Nobiletin inhibited tumor angiogenesis by regulating Src, FAK, and STAT3 signaling through PXN in ER+ breast cancer cells.

Author supplied keywords

Cite

CITATION STYLE

APA

Nipin, S. P., Kang, D. Y., Joung, Y. H., Park, J. H., Kim, W. S., Lee, H. K., … Yang, Y. M. (2017). Nobiletin inhibits angiogenesis by regulating Src/FAK/STAT3-mediated signaling through PXN In ER+ breast cancer cells. International Journal of Molecular Sciences, 18(5). https://doi.org/10.3390/ijms18050935

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free